Equities

Forecasts data is unavailable for this security.

Consensus recommendation

As of Jul 21, 2017, the consensus forecast amongst 20 polled investment analysts covering Procter & Gamble Co advises that the company will outperform the market. This has been the consensus forecast since the sentiment of investment analysts improved on Jan 18, 2016. The previous consensus forecast advised investors to hold their position in Procter & Gamble Co.
  • 1yr ago
  • 3M ago
  • 2M ago
  • 1M ago
  • Latest
Select bar for recommendation details.
RecommendationsLatest
Buy6
Outperform2
Hold10
Underperform2
Sell0

Share price forecast

The 16 analysts offering 12 month price targets for Procter & Gamble Co have a median target of 91.50, with a high estimate of 102.00 and a low estimate of 80.00. The median estimate represents a 3.26% increase from the last price of 88.61.
High15.1%102.00
Med3.3%91.50
Low-9.7%80.00

Dividends

In 2016, Procter & Gamble Co reported a dividend of 2.66 USD, which represents a 2.49% increase over last year. The 14 analysts covering the company expect dividends of 2.71 USD for the upcoming fiscal year, an increase of 2.02%.
Div growth (TTM)2.49%
More ▼

Earnings history & estimates

On Apr 26, 2017, Procter & Gamble Co reported 3rd quarter 2017 earnings of 0.96 per share. This result was in line with the consensus of the 19 analysts following the company and exceeded last year's 3rd quarter results by 11.63%.
The next earnings announcement is expected on Jul 27, 2017.
Average growth rate+4.00%
Procter & Gamble Co reported annual 2016 earnings of 3.67 per share on Aug 02, 2016.
The next earnings announcement from Procter & Gamble Co is expected the week of Jul 27, 2017.
Average growth rate-1.01%
More ▼

Revenue history & estimates

The Procter & Gamble Company had 3rd quarter 2017 revenues of 15.61bn. This missed the 15.74bn consensus estimate of the 16 analysts following the company. This was 0.95% below the prior year's 3rd quarter results.
Average growth rate-0.15%
The Procter & Gamble Company had revenues for the full year 2016 of 65.30bn. This was 14.39% below the prior year's results.
Average growth rate-5.82%
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.